Shekel Brainweigh Ltd - Aiming for EBITDA Breakeven in Q4 CY23
324 Views30 Apr 2023 21:32
Issuer-paid
- Shekel Brainweigh Limited (ASX:SBW) reported FY22 sales growth of 14% to US$26.3m, which included 117% growth in Retail Innovation sales to $US2.0m.
- Revenue growth has continued into Q1 FY23 with 13% underlying growth, driven by 32% growth in the Self-Checkout division.
- We estimate an adjusted FY22 EBITDA loss (before amortisation, one-off costs and share-based payments) of US$3.3m, in-line with CY21 and impacted by a ~530bps decline in gross margin, predominantly in H2 FY22.
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)